Developments in China’s biotechnology sector, from research breakthroughs and diagnostics to industrial biotech and manufacturing.
A new wave of regulatory caution from Beijing is redefining the pathway for Chinese tech and biotech firms seeking offshore listings, with significant implications for global investors, IPO candidates, and…
A profitable Hong Kong-based biotechnology company is moving toward a public listing to finance the development of treatments for Alzheimer’s and other neurological diseases, a sign that China’s biotech ambitions…
The Missing Black Holes: A Gravitational-Wave Clue to Stellar Annihilation For six decades, astrophysicists have theorized the existence of a stellar cataclysm so violent it leaves no trace—a supernova that…
For global biotech professionals and investors, the contrast between Hong Kong and Singapore offers a cautionary tale—and a reminder that institutional infrastructure, talent pipelines, and regulatory clarity matter as much…
For global pharmaceutical professionals, the prospect of a Chinese company successfully navigating US biological drug approval for the first time signals a shift in competitive dynamics that extends well beyond…
Take Away China’s biotech sector is no longer content with manufacturing generics; it is now a primary arena for strategic national investment, aiming to redefine its role in the global…
For global biotech investors and pharmaceutical strategists, the lesson is clear: China’s life sciences future is increasingly a story of regional ecosystems, not just national ambition. More than three decades…
A Chinese diagnostic firm’s plan to expand in Hong Kong signals how pandemic-era public health partnerships can become a launchpad for long-term commercial strategy in one of Asia’s most competitive…
The move signals a strategic pivot from unfettered capital access to controlled growth, prioritizing regulatory oversight and national interest in sensitive sectors. Chinese regulators are adopting a stricter stance toward…
Three decades of parallel biotech ambition have left Hong Kong trailing Singapore by a significant distance. Yet the emergence of the Greater Bay Area offers a second chance — one…
No products in the cart.
